We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
MYNZ

Price
3.22
Stock movement up
+0.02 (0.63%)
Company name
Mainz Biomed BV
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Diagnostics & Research
Market cap
6.45M
Ent value
11.54M
Price/Sales
7.50
Price/Book
1.98
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-91.56%
3 year return
-82.33%
5 year return
-
10 year return
-
Last updated: 2025-04-18

iO Charts is a Seeking Alpha partner

DIVIDENDS

MYNZ does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales7.50
Price to Book1.98
EV to Sales13.41

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count2.00M
EPS (TTM)-47.09
FCF per share (TTM)-41.00

Income statement

Loading...
Income statement data
Revenue (TTM)860.14K
Gross profit (TTM)505.45K
Operating income (TTM)-26.96M
Net income (TTM)-24.92M
EPS (TTM)-47.09
EPS (1y forward)-9.20

Margins

Loading...
Margins data
Gross margin (TTM)58.76%
Operating margin (TTM)-3134.06%
Profit margin (TTM)-2897.00%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash7.07M
Net receivables354.51K
Total current assets8.98M
Goodwill0.00
Intangible assets3.39M
Property, plant and equipment0.00
Total assets15.41M
Accounts payable2.33M
Short/Current long term debt7.42M
Total current liabilities9.24M
Total liabilities12.16M
Shareholder's equity3.25M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-20.93M
Capital expenditures (TTM)759.72K
Free cash flow (TTM)-21.69M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-766.89%
Return on Assets-161.71%
Return on Invested Capital-294.05%
Cash Return on Invested Capital-256.01%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open3.33
Daily high3.33
Daily low3.03
Daily Volume39K
All-time high1110.40
1y analyst estimate2.00
Beta0.08
EPS (TTM)-47.09
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
MYNZS&P500
Current price drop from All-time high-99.71%-14.12%
Highest price drop-99.74%-56.47%
Date of highest drop1 Apr 20259 Mar 2009
Avg drop from high-79.18%-11.07%
Avg time to new high108 days12 days
Max time to new high813 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
MYNZ (Mainz Biomed BV) company logo
Marketcap
6.45M
Marketcap category
Small-cap
Description
Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. It has a collaboration agreement with Thermo Fisher Scientific Inc. for the development of colorectal cancer screening product. The company was founded in 2008 and is based in Mainz, Germany.
Employees
65
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...